Skip to main content
Top
Published in: International Journal of Hematology 5/2008

01-12-2008 | Original Article

Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27

Authors: Shima Uneda, Minako Gotoh, Takashi Sonoki, Kazuhiro Nishida, Yasushi Nakamura, Miwa Kurimoto, Nobuyoshi Hanaoka, Hiroshi Matsuoka, Masafumi Taniwaki, Hideki Nakakuma

Published in: International Journal of Hematology | Issue 5/2008

Login to get access

Abstract

We established a novel mature B-cell line from a CD5 and CD10 double-positive diffuse large B-cell lymphoma patient, designated as WILL1. WILL1 cells were positive for CD5, CD10, CD19, and CD20. Spectral karyotype (SKY) analysis revealed chromosome 8 signals on 6q27 as well as 14q32. Fluorescence in situ hybridization (FISH) analysis suggested that a translocation break occurred outside the immunoglobulin heavy chain (IGH) gene on 14q32. Moreover, fusion signals of IGH and C-MYC probes were detected on the derivative 6 and derivative 14 chromosomes. Southern blot analysis using a C-MYC exon II fragment failed to detect rearrangement, suggesting that the 8q24 breakpoints lay far up- or downstream of the C-MYC gene. WILL1 is a useful tool to analyze the pathogenesis of CD5 and CD10 double-positive diffuse large B-cell lymphoma, and for molecular cloning of the unique translocation breakpoints of 14q32 and 8q24 and a novel gene on 6q27.
Literature
5.
go back to reference Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 2000;96:808–22.PubMed Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 2000;96:808–22.PubMed
6.
7.
go back to reference Akasaka T, Akasaka H, Ueda C, et al. Molecular and clinical features of non-Burkitt’s, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene. J Clin Oncol. 2000;18:510–8.CrossRefPubMed Akasaka T, Akasaka H, Ueda C, et al. Molecular and clinical features of non-Burkitt’s, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene. J Clin Oncol. 2000;18:510–8.CrossRefPubMed
9.
go back to reference Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt’s lymphoma: relevance to geography and Epstein-Barr virus association. Blood. 1991;77:1516–26.PubMed Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt’s lymphoma: relevance to geography and Epstein-Barr virus association. Blood. 1991;77:1516–26.PubMed
10.
go back to reference Dyer MJ, Lillington DM, Bastard C, et al. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus. Leukemia. 1996;10:1198–208.PubMed Dyer MJ, Lillington DM, Bastard C, et al. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus. Leukemia. 1996;10:1198–208.PubMed
11.
go back to reference Knezevich S, Ludkovski O, Salski C, et al. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas. Leukemia. 2005;19:659–63.CrossRefPubMed Knezevich S, Ludkovski O, Salski C, et al. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas. Leukemia. 2005;19:659–63.CrossRefPubMed
13.
go back to reference Zani VJ, Asou N, Jadayel D, et al. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood. 1996;87:3124–34.PubMed Zani VJ, Asou N, Jadayel D, et al. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood. 1996;87:3124–34.PubMed
14.
go back to reference Sonoki T, Ishihara S, Uneda S, et al. Aggressive CD5-positive B-cell lymphoma after remission of CD5-negative follicular lymphoma with distinct immunoglobulin heavy chain rearrangement and translocation. Int J Hematol. 2008;88:299–303.CrossRefPubMed Sonoki T, Ishihara S, Uneda S, et al. Aggressive CD5-positive B-cell lymphoma after remission of CD5-negative follicular lymphoma with distinct immunoglobulin heavy chain rearrangement and translocation. Int J Hematol. 2008;88:299–303.CrossRefPubMed
15.
go back to reference Sonoki T, Matsuzaki H, Miyamoto K, et al. Establishment of the novel B acute lymphoblastic leukemia (FAB L3) cell line KHM-10B with a 13q34 abnormality and constitutive expression of c-myc and max during cell cycle. Leukemia. 1995;9:2093–9.PubMed Sonoki T, Matsuzaki H, Miyamoto K, et al. Establishment of the novel B acute lymphoblastic leukemia (FAB L3) cell line KHM-10B with a 13q34 abnormality and constitutive expression of c-myc and max during cell cycle. Leukemia. 1995;9:2093–9.PubMed
16.
go back to reference Nagasaki A, Gotoh T, Takeya M, et al. Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats. RNA blot, immunoblot, and immunohistochemical analyses. J Biol Chem. 1996;271:2658–62. doi:10.1074/jbc.271.5.2658.CrossRefPubMed Nagasaki A, Gotoh T, Takeya M, et al. Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats. RNA blot, immunoblot, and immunohistochemical analyses. J Biol Chem. 1996;271:2658–62. doi:10.​1074/​jbc.​271.​5.​2658.CrossRefPubMed
17.
go back to reference Kakazu N, Taniwaki M, Horiike S, et al. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes Cancer. 1999;26:336–45. doi:10.1002/(SICI)1098-2264(199912)26:4<336::AID-GCC8>3.0.CO;2-H.CrossRefPubMed Kakazu N, Taniwaki M, Horiike S, et al. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes Cancer. 1999;26:336–45. doi:10.1002/(SICI)1098-2264(199912)26:4<336::AID-GCC8>3.0.CO;2-H.CrossRefPubMed
18.
19.
go back to reference Taya Y, Hosogai K, Hirohashi S, et al. A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer. EMBO J. 1984;3:2943–6.PubMedPubMedCentral Taya Y, Hosogai K, Hirohashi S, et al. A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer. EMBO J. 1984;3:2943–6.PubMedPubMedCentral
21.
24.
go back to reference Siebert R, Matthiesen P, Harder S, et al. Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood. 1998;91:984–90.PubMed Siebert R, Matthiesen P, Harder S, et al. Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood. 1998;91:984–90.PubMed
25.
go back to reference Joos S, Falk MH, Lichter P, Haluska FG, et al. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. Hum Mol Genet. 1992;1:625–32. doi:10.1093/hmg/1.8.625.CrossRefPubMed Joos S, Falk MH, Lichter P, Haluska FG, et al. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. Hum Mol Genet. 1992;1:625–32. doi:10.​1093/​hmg/​1.​8.​625.CrossRefPubMed
30.
31.
go back to reference Sonoki T, Tatetsu H, Nagasaki A, et al. Molecular cloning of translocation breakpoint from der(8)t(3;8)(q27;q24) defines juxtaposition of downstream of C-MYC and upstream of BCL6. Int J Hematol. 2007;86:196–8. doi:10.1532/IJH97.07083.CrossRefPubMed Sonoki T, Tatetsu H, Nagasaki A, et al. Molecular cloning of translocation breakpoint from der(8)t(3;8)(q27;q24) defines juxtaposition of downstream of C-MYC and upstream of BCL6. Int J Hematol. 2007;86:196–8. doi:10.​1532/​IJH97.​07083.CrossRefPubMed
Metadata
Title
Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27
Authors
Shima Uneda
Minako Gotoh
Takashi Sonoki
Kazuhiro Nishida
Yasushi Nakamura
Miwa Kurimoto
Nobuyoshi Hanaoka
Hiroshi Matsuoka
Masafumi Taniwaki
Hideki Nakakuma
Publication date
01-12-2008
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2008
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-008-0189-x

Other articles of this Issue 5/2008

International Journal of Hematology 5/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine